HPV Genotyping Testing

The procurement process for HPV Genotyping Testing has been completed by Gateshead Health NHS Foundation Trust, a regional authority located in Gateshead, United Kingdom. This contract falls under the services category specified by the CPV code 85145000, indicative of services provided by medical laboratories. The procurement was conducted through a limited process, specifically a direct award procedure without prior publication, based on the Provider Selection Regime governed by the Health Care Services Regulations 2023.

The contract, valued at approximately £6,000, covers the provision of services from 2025 to 2028, with NHS Lothian being awarded the contract. It was concluded that NHS Lothian was the only capable provider, as confirmed in the award notice dated 17th July 2025. This tender presents opportunities for growth primarily for large-scale medical laboratories, especially those involved in genotyping and related services.

Companies with the capability to deliver specialised medical services competitive to NHS Lothian's can leverage this framework, especially in cases where direct awards are permissible under specific regulatory conditions like the Provider Selection Regime. Given the unique nature of this award, businesses interested in similar procurement opportunities could benefit by ensuring they meet qualification criteria for direct awards and by demonstrating unique capabilities that might bridge service gaps in specialised healthcare provision. The focus on patient choice and lack of viable alternatives stresses the importance of establishing niche competencies in this sector.